Treatment of malignant ascites.
The management of malignant ascites is a significant challenge in gastrointestinal medical oncology. Current treatment strategies include diuretic therapy, paracentesis, peritoneal drains, and venous shunts. However, there are no established evidence-based guidelines, and there is a lack of randomized controlled trials identifying optimal therapy. Newer therapies are emerging and will need further study. By summarizing published studies, this review is intended to add some clarity to currently available strategies for the management of malignant ascites associated with hepatobiliary cancers. Notably, however, much of the available data for the management of malignant ascites comes from the gynecologic oncology experience, specifically from studies in ovarian cancer. Therefore, successful approaches used in this malignancy may be lead candidates for development in hepatobiliary cancer-associated ascites and are reviewed in this paper.
Chung
Michael
M
Beth Israel Medical Center, New York, NY 10003, USA.
Kozuch
Peter
P
D000911:Antibodies, Monoclonal; D001201:Ascites / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy*; D002986:Clinical Trials as Topic; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008297:Male; D020782:Matrix Metalloproteinases / Q000378:metabolism; D008495:Medical Oncology / Q000379:methods; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D012107:Research Design; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D020782:Matrix Metalloproteinases
Arch Intern Med. 1979 Feb;139(2):235
434979
Am J Hosp Palliat Care. 2002 Jan-Feb;19(1):7-8
12171427
Cancer Res. 1992 Mar 1;52(5):1252-8
1737387
Acta Pathol Microbiol Scand. 1953;33(1):10-21
13113944
N Engl J Med. 1994 Feb 3;330(5):337-42
8277955
J Nucl Med. 1975 Apr;16(4):318-9
1113189
Cancer. 1993 Mar 15;71(6):2027-30
7680276
Med Oncol Tumor Pharmacother. 1992;9(4):177-81
1342062
Gynecol Oncol. 1983 Aug;16(1):6-14
6884832
Surgery. 1983 Mar;93(3):365-73
6600854
Anticancer Res. 1998 Sep-Oct;18(5D):3917-25
9854504
Am J Clin Oncol. 1982 Apr;5(2):167-72
6178284
Am Surg. 2000 Jun;66(6):561-8
10888132
J Pain Symptom Manage. 1998 Aug;16(2):96-101
9737100
J Pain Symptom Manage. 1995 Apr;10(3):237-42
7629417
Cancer. 1984 Nov 15;54(10):2226-30
6207907
J Gastroenterol Hepatol. 2007 Dec;22(12):2161-6
18031375
J Vasc Interv Radiol. 2001 Mar;12(3):373-5
11287517
Ann Oncol. 2007 May;18(5):945-9
17298959
Eur J Surg Oncol. 2006 Aug;32(6):682-5
16631341
Cancer. 1986 Feb 15;57(4):721-7
2417681
Cancer. 1966 Aug;19(8):1096-102
5912325
Clin Oncol (R Coll Radiol). 2003 Apr;15(2):59-72
12708713
Can J Oncol. 1996 Nov;6(2):474-80
12056099
Palliat Med. 1999 Sep;13(5):429-30
10659116
J Clin Oncol. 2003 Oct 15;21(20):3737-43
14551293
Br J Cancer. 2003 Nov 17;89(10):1876-84
14612896
Eur J Surg Oncol. 1990 Feb;16(1):47-53
1689678
Gynecol Oncol. 1978 Feb;6(1):106-10
413767
Eur J Cancer. 2006 Mar;42(5):589-97
16434188
J Nucl Med. 1960 Jul;1:195-8
13876489
Gynecol Oncol. 1997 Jan;64(1):80-7
8995552
Clin Cancer Res. 2007 Jul 1;13(13):3899-905
17606723
Gastroenterology. 1992 Oct;103(4):1302-6
1397889
Anticancer Res. 2000 Jan-Feb;20(1A):155-60
10769648
Anticancer Drugs. 1994 Jun;5(3):305-8
7522646
Am Surg. 2001 Oct;67(10):999-1003
11603562
Eur J Cancer. 1991;27(2):121-5
1827272
Ann Intern Med. 1992 Aug 1;117(3):215-20
1616215
Hepatology. 1988 Sep-Oct;8(5):1104-9
3417231
J Am Med Assoc. 1955 Dec 31;159(18):1704-7
13271133
J Am Coll Surg. 2004 Jun;198(6):999-1011
15194082
Clin Cancer Res. 1996 Jul;2(7):1207-14
9816289
J Surg Oncol. 1982 Aug;20(4):238-42
6180252
Anticancer Res. 1994 Mar-Apr;14(2B):739-45
7516642
Gynecol Oncol. 1992 Oct;47(1):102-9
1427388
Gan To Kagaku Ryoho. 1993 Aug;20(11):1622-5
8373233
Jpn J Clin Oncol. 2007 Dec;37(12):930-5
18211984
Am Surg. 1997 Feb;63(2):137-43
9012427
Cancer. 1989 Sep 1;64(5):1029-33
2758381
Surg Oncol Clin N Am. 2003 Jul;12(3):865-72, xvi-xvii
14567037
N Engl J Med. 2004 Apr 15;350(16):1646-54
15084697
In Vivo. 1991 Nov-Dec;5(6):579-81
1810442
J Cancer Res Clin Oncol. 1992;118(7):547-50
1624547
Cancer. 1982 Sep 15;50(6):1204-9
7104966
Surgery. 1983 Mar;93(3):357-64
6187080
Eur J Surg Oncol. 1996 Jun;22(3):237-9
8654603
Clin Cancer Res. 1998 Aug;4(8):1899-902
9717817
Cancer. 1986 Feb 1;57(3):461-4
2417677
Invest New Drugs. 1999;17(4):387-99
10759405
Oncology. 2001;61(3):192-6
11574774
J Clin Oncol. 1990 Dec;8(12):2054-61
2230897
Support Care Cancer. 2000 Nov;8(6):493-9
11094995
Cancer Res. 1998 Jun 15;58(12):2594-600
9635584
Acta Cytol. 1993 Jul-Aug;37(4):483-8
8328242
J Pain Symptom Manage. 2000 Mar;19(3):193-9
10760624
J Vasc Interv Radiol. 2004 Oct;15(10):1129-31
15466800
J Am Med Assoc. 1958 Feb 8;166(6):597-9
13502033
Clin Oncol (R Coll Radiol). 2005 Apr;17(2):118-21
15830574
Eur J Surg Oncol. 1997 Dec;23(6):526-31
9484924
Ann Surg Oncol. 1994 Sep;1(5):378-81
7531600
Oncologist. 2000;5 Suppl 1:45-50
10804091
J Chir (Paris). 1997 Nov;134(5-6):237-42
9772980
Arch Intern Med. 1959 Nov;104:802-15
13818972